// company-profile

First Tracks Biotherapeutics, Inc. Insider Trading

TRAX

Every SEC Form 4 insider trading filing for First Tracks Biotherapeutics, Inc. (TRAX) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.

ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings36Insiders12
// api This First Tracks Biotherapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
curl "https://api.form4api.com/v1/transactions?ticker=TRAX" -H "X-Api-Key: YOUR_API_KEY"

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 3 insiders purchased shares. Buying was led by Faga Daniel.

// 90-day insight

Over the last 90 days, First Tracks Biotherapeutics, Inc. insiders bought $0 across 36 transactions with no open-market sales.

  • Most active insider: Jain Rita with 5 transactions totaling $0.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 2, 2026Faga DanielTRAX
Award
193,576$0.00$0K
Aug 2, 2026Lizzul Paul F.TRAX
Award
60,492$0.00$0K
Aug 2, 2026STONE BENJAMINTRAX
Award
60,492$0.00$0K
Jun 15, 2026Ware J. AnthonyTRAX
Option Exercise
6,030$0.00$0K
Jun 15, 2026Orwin John ATRAX
Option Exercise
6,030$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →